| Literature DB >> 31491037 |
Rei-Yeuh Chang1,2,3, Han-Lin Tsai1, Ping-Gune Hsiao1, Chao-Wen Tan1, Chi-Pin Lee1, I-Tseng Chu1, Yung-Ping Chen1, Malcolm Koo4,5.
Abstract
INTRODUCTION: Heart rate recovery (HRR) is a marker of parasympathetic activity recovery after exercise, and it is associated with cardiovascular mortality and total mortality. Impaired renal function is also associated with cardiac mortality. The aim of this study was to investigate the association between HRR after exercise and renal function in patients referred for a treadmill exercise test. PATIENTS AND METHODS: This cross-sectional study was conducted at a regional hospital in southern Taiwan. Patients who completed a symptom-limited treadmill exercise test from January 2015 to February 2018 were recruited. Before the treadmill exercise test, patients were asked to complete a questionnaire on the past disease history and lifestyle factors. Serum creatinine measurement within two years prior to or after the date of the treadmill exercise test of the patients was also obtained from the medical records for these patients. Estimated glomerular filtration rate (eGFR) was calculated. Simple and multiple linear regression analyses were performed to investigate the association between one-minute HRR and eGFR.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31491037 PMCID: PMC6730871 DOI: 10.1371/journal.pone.0222236
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic and clinical characteristics of study participants (N = 2153).
| Variable | Number (%) or mean (standard deviation) |
|---|---|
| Age, years | 53.4 (11.7) |
| Sex, male | 1196 (55.6) |
| Body mass index, kg/m2 | 25.6 (3.9) |
| Waist circumference, cm | 86.3 (10.6) |
| eGFR, mL/min/1.73m2 | 106.6 (29.8) |
| Chronic kidney disease stage | |
| Stage 1 | 1566 (72.7) |
| Stage 2 | 499 (23.2) |
| Stage 3a | 56 (2.6) |
| Stage 3b | 14 (0.7) |
| Stage 4 | 6 (0.3) |
| Stage 5 | 12 (0.6) |
| Hypertension | 786 (36.5) |
| Type 2 diabetes mellitus | 324 (15.0) |
| Coronary artery disease | 327 (15.2) |
| Hyperlipidemia | 406 (18.9) |
| Chronic obstructive pulmonary disease | 26 (1.2) |
| Smoking | 380 (17.6) |
| Alcohol use | 363 (16.9) |
| Exercise | 1296 (60.2) |
| Poor sleep quality (PSQI > 5) | 233 (10.8) |
| Perceived health status | |
| Very good or good | 232 (10.8) |
| Fair | 1275 (59.2) |
| Poor or very poor | 646 (30.0) |
eGFR, estimated glomerular filtration rate; PSQI, Pittsburgh Sleep Quality Index.
Chronic kidney disease stages were defined as follows: stage 1, eGFR≥ 90 mL/min/1.73m2; stage 2, eGFR 60–89 mL/min/1.73m2; stage 3a, eGFR 45–59 mL/min/1.73m2; stage 3b, eGFR 30–44 mL/min/1.73m2; stage 4, eGFR 15–29 mL/min/1.73m2; and stage 5, eGFR<15 mL/min/1.73m2.
Poor sleep quality was defined as a Pittsburgh Sleep Quality Index score of > 5.
Exercise was dichotomized with a cut-off of ≥ 3 days/week with duration ≥ 30 min.
Results of treadmill maximal exercise test.
| Variable | Number (%) or mean (standard deviation) |
|---|---|
| One-minute heart rate recovery, bpm | 22.1 (9.5) |
| Rate-pressure product reserve, mmHg × bpm × 10−2 | 16.2 (4.6) |
| Functional capacity, MET | 9.5 (2.9) |
| Arrhythmia | |
| APC | 112 (5.2) |
| VPC | 256 (11.9) |
| SVT | 6 (0.3) |
| AF | 4 (0.2) |
| VT | 4 (0.2) |
| Ischemia | |
| Negative | 1598 (74.2) |
| Positive | 424 (19.7) |
| Inconclusive | 131 (6.1) |
AF, atrial flutter; APC, atrial premature contraction; BPM, beats per minute; MET, metabolic equivalent of task; SVT, supraventricular tachycardia; VPC, ventricular premature contraction; VT, ventricular tachycardia.
Simple and multiple linear regression analyses of one-minute heart rate recovery.
| Variable | Simple linear regression | Multiple linear regression | Multiple linear regression | ||||||
|---|---|---|---|---|---|---|---|---|---|
| b | Std β | b | Std β | b | Std β | ||||
| Age, years | −0.175 | −0.216 | < 0.001 | −0.145 | −0.179 | < 0.001 | −0.137 | −0.169 | < 0.001 |
| Sex (female as reference) | −2.053 | −0.107 | < 0.001 | – | – | – | – | – | – |
| Body mass index, kg/m2 | −0.392 | −0.160 | < 0.001 | – | – | – | – | – | – |
| Waist circumference, cm | −0.182 | −0.203 | < 0.001 | −0.138 | −0.154 | < 0.001 | −0.139 | −0.155 | < 0.001 |
| Hypertension | −2.668 | −0.135 | < 0.001 | – | – | – | – | – | – |
| Type 2 diabetes mellitus | −4.662 | −0.175 | < 0.001 | −2.338 | −0.088 | < 0.001 | −2.702 | −0.101 | < 0.001 |
| Coronary artery disease | −2.081 | −0.078 | < 0.001 | – | – | – | – | – | – |
| Hyperlipidemia | −1.297 | −0.053 | 0.014 | – | – | – | – | – | – |
| Chronic obstructive pulmonary disease | −1.869 | −0.021 | 0.321 | – | – | – | – | – | – |
| Smoking | −1.905 | −0.076 | < 0.001 | −2.057 | −0.082 | < 0.001 | −1.949 | −0.078 | < 0.001 |
| Alcohol use | −0.749 | −0.029 | 0.173 | – | – | – | – | – | – |
| Exercise | 0.169 | 0.009 | 0.687 | – | – | – | – | – | – |
| Perceived health status (very good or good as reference) | – | – | – | – | |||||
| Fair | −0.636 | −0.033 | 0.351 | – | – | – | – | – | – |
| Poor or very poor | −1.487 | −0.071 | 0.042 | – | – | – | – | – | – |
| Poor sleep quality | −0.891 | −0.029 | 0.179 | – | – | – | – | – | – |
| Estimated glomerular filtration rate, mL/min/1.73m2 | 0.065 | 0.202 | < 0.001 | Not evaluated in Model 1 | 0.036 | 0.112 | < 0.001 | ||
| Chronic kidney disease stage (stage 1 as reference) | Not evaluated in Model 2 | ||||||||
| Stage 2 | −3.574 | −0.155 | < 0.001 | −1.940 | −0.084 | < 0.001 | – | – | – |
| Stage 3a | −7.708 | −0.118 | < 0.001 | −3.958 | −0.061 | 0.004 | – | – | – |
| Stages 3b, 4, 5 | −8.169 | −0.100 | < 0.001 | −5.197 | −0.064 | 0.002 | – | – | – |
b: beta coefficient; std β: standardized beta coefficient.
Exercise was dichotomized with a cut-off of ≥ 3 days/week with duration ≥ 30 min.
Poor sleep quality was defined as a Pittsburgh Sleep Quality Index score of > 5.
Linear trend test for the stages of chronic kidney disease, P < 0.001.